MRVI Stage 2 Uptrend Intact, 7/8 Trend Template Checks Pass

Posted on by Eben@CANSLIM Research
MRVI daily stock chart with 10, 20, 50, 150 and 200-day moving averages, volume and RS line versus SPY — CANSLIM Research

MRVI is trading at $7.49 in a confirmed Stage 2 advance, holding above a rising 30-week moving average with a 14.2% six-week slope. The market is focused on the stock’s strong trend template, which passes seven of eight checks, including price above all key moving averages and a 217% gain off its 52-week low. However, the lack of a proper base and the RS line not at a three-month high temper the bullish setup, leaving sentiment bullish but cautious.

As of 2026-09-01 · Close $7.49

Stage 2 (Advancing) — Price holding above a rising 30-week MA — uptrend intact (30-week MA 6-week slope: 14.22%)

Continue Reading

This article is for pass holders.

Already a pass holder? Sign in · Continue with Google

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.

Related Posts